Prostate tissue composition and MR measurements: investigating the relationships between ADC, T2, K(trans), v(e), and corresponding histologic features.
暂无分享,去创建一个
[1] Bin Wang,et al. Diffusion‐weighted imaging of prostate cancer: Correlation between apparent diffusion coefficient values and tumor proliferation , 2009, Journal of magnetic resonance imaging : JMRI.
[2] Gary Liney,et al. Correlation of diffusion‐weighted magnetic resonance data with cellularity in prostate cancer , 2009, BJU international.
[3] H. Hricak,et al. Correlation of MR imaging and MR spectroscopic imaging findings with Ki-67, phospho-Akt, and androgen receptor expression in prostate cancer. , 2009, Radiology.
[4] Georg Heinze,et al. Morphometric signature differences in nuclei of Gleason pattern 4 areas in Gleason 7 prostate cancer with differing primary grades on needle biopsy. , 2009, The Journal of urology.
[5] Olivier Rouvière,et al. Evaluation of T2-weighted and dynamic contrast-enhanced MRI in localizing prostate cancer before repeat biopsy , 2009, European Radiology.
[6] Katsuyoshi Ito,et al. Apparent diffusion coefficient values in peripheral and transition zones of the prostate: Comparison between normal and malignant prostatic tissues and correlation with histologic grade , 2008, Journal of magnetic resonance imaging : JMRI.
[7] Gerardo Fernandez,et al. Systems pathology approach for the prediction of prostate cancer progression after radical prostatectomy. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] N M deSouza,et al. Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer. , 2008, Clinical radiology.
[9] Jason A Koutcher,et al. Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging--correlation with pathologic findings. , 2008, Radiology.
[10] Y. Liu,et al. Dynamic contrast-enhanced MRI of benign prostatic hyperplasia and prostatic carcinoma: correlation with angiogenesis. , 2008, Clinical radiology.
[11] Masoom A Haider,et al. Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. , 2007, AJR. American journal of roentgenology.
[12] R. Lenkinski,et al. 3T MR of the prostate: Reducing susceptibility gradients by inflating the endorectal coil with a barium sulfate suspension , 2007, Magnetic resonance in medicine.
[13] M. Kattan,et al. The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis , 2007, BJU international.
[14] N. deSouza,et al. MAGNETIC RESONANCE IMAGING IN PROSTATE CANCER : VALUE OF APPARENT DIFFUSION COEFFICIENTS FOR IDENTIFYING MALIGNANT NODULES , 2010 .
[15] M. Reiser,et al. Per-sextant localization and staging of prostate cancer: correlation of imaging findings with whole-mount step section histopathology. , 2007, AJR. American journal of roentgenology.
[16] D J Collins,et al. Evaluation of response to treatment using DCE-MRI: the relationship between initial area under the gadolinium curve (IAUGC) and quantitative pharmacokinetic analysis , 2006, Physics in medicine and biology.
[17] Silvia D. Chang,et al. Combined diffusion‐weighted and dynamic contrast‐enhanced MRI for prostate cancer diagnosis—Correlation with biopsy and histopathology , 2006, Journal of magnetic resonance imaging : JMRI.
[18] M. Kattan,et al. Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy. , 2005, Radiology.
[19] Takeo Ishigaki,et al. Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate , 2005, Journal of magnetic resonance imaging : JMRI.
[20] Vassilis Poulakis,et al. Preoperative neural network using combined magnetic resonance imaging variables, prostate-specific antigen, and gleason score for predicting prostate cancer biochemical recurrence after radical prostatectomy. , 2004, Urology.
[21] Michael J. Wilson,et al. Microvessel density as a molecular marker for identifying high-grade prostatic intraepithelial neoplasia precursors to prostate cancer. , 2004, Experimental and molecular pathology.
[22] K. Hosseinzadeh,et al. Endorectal diffusion‐weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue , 2004, Journal of magnetic resonance imaging : JMRI.
[23] Mark Rijpkema,et al. Combined quantitative dynamic contrast‐enhanced MR imaging and 1H MR spectroscopic imaging of human prostate cancer , 2004, Journal of magnetic resonance imaging : JMRI.
[24] H. Hricak,et al. Chronic prostatitis: MR imaging and 1H MR spectroscopic imaging findings--initial observations. , 2004, Radiology.
[25] H. Schlemmer,et al. Can pre-operative contrast-enhanced dynamic MR imaging for prostate cancer predict microvessel density in prostatectomy specimens? , 2004, European Radiology.
[26] Henkjan J Huisman,et al. Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. , 2003, Radiology.
[27] B. Rutt,et al. Rapid combined T1 and T2 mapping using gradient recalled acquisition in the steady state , 2003, Magnetic resonance in medicine.
[28] B. Issa,et al. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo‐planar imaging , 2002, Journal of magnetic resonance imaging : JMRI.
[29] Peter Gibbs,et al. Comparison of quantitative T2 mapping and diffusion‐weighted imaging in the normal and pathologic prostate , 2001, Magnetic resonance in medicine.
[30] J Kurhanewicz,et al. Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. , 2000, The Journal of urology.
[31] D P Dearnaley,et al. Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA. , 2000, Clinical radiology.
[32] P. Carroll,et al. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study. , 1999, Radiology.
[33] M. Kattan,et al. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. , 1998, Journal of the National Cancer Institute.
[34] S. Piantadosi,et al. Correlation of prostate needle biopsy and radical prostatectomy Gleason grade in academic and community settings. , 1997, The American journal of surgical pathology.
[35] P. Tofts. Modeling tracer kinetics in dynamic Gd‐DTPA MR imaging , 1997, Journal of magnetic resonance imaging : JMRI.
[36] J R Thornbury,et al. Local staging of prostate cancer with endorectal MR imaging: correlation with histopathology. , 1996, AJR. American journal of roentgenology.
[37] R. Herfkens,et al. Determining the volume of prostatic carcinoma: value of MR imaging with an external-array coil. , 1993, AJR. American journal of roentgenology.
[38] P H Bland,et al. Prostate cancer: correlation of MR images with tissue optical density at pathologic examination. , 1991, Radiology.
[39] L Axel,et al. Prostatic carcinoma and benign prostatic hyperplasia: correlation of high-resolution MR and histopathologic findings. , 1989, Radiology.
[40] D G Mitchell,et al. The biophysical basis of tissue contrast in extracranial MR imaging. , 1987, AJR. American journal of roentgenology.